investors-2019-new

Investor Overview

We are well positioned in both developing and developed markets. As the largest pharmaceutical company in Africa, we have an expanding presence in Latin America, Asia, Europe and the Commonwealth of Independent States, comprising Russia and the former Soviet Republics (“CIS”). We are also one of the leading pharmaceutical companies in Australia and are establishing a presence in other developed markets such as the United States of America (“USA”) and Canada.

With an extensive basket of products that provide treatment for a broad spectrum of acute and chronic conditions experienced throughout all stages of life, we continue to increase the number of lives benefiting from our products, reaching more than 150 countries across the world.

INVESTMENT PROPOSITION

Strong market position


Diversified geographies and product offering


Proven track record


Leverages on local knowledge and expertise

Centralised Group activities facilitate synergies and mitigate pricing pressures


Positive growth drivers


Responsible corporate citizen


Other considerations

INVESTOR CALENDAR

30 June 2019

Financial year end

12 September 2019

Year end results announcement and presentation in Johannesburg

November 2019

Publishing of the Integrated Report

5 December 2019

Annual General Meeting

SENS ANNOUNCEMENTS

SHARE PRICE CENTRE

View share price information for Aspen Holdings.

SHARE CODE

APN ISIN: ZAE 000066692

JSE data delayed by 15 minutes, page refreshes every 5 minutes. Indicated trade times are actual.

PRESENTATIONS

Aspen's Year End Results presentation for the year ended 30 June 2019
PDF 1.08MB

 

CAPITAL DISTRIBUTIONS

All capital distributions to date

SHAREHOLDER STATISTICS

Analysis of shareholders at 30 June 2018

CORPORATE INFORMATION

All corporate information and contact details

CONTACT DETAILS

Luresha Chetty
+27 31 580 8637
InvestorRelations@aspenpharma.com

WEBCAST

Click here to view the webcast of Aspen's year end results presentation for the year ended 30 June 2019.